关于他类药物的不良反应和潜在机制的进展:系统性审查
Weiwei Zeng1, Huan Deng1, Yuning Luo1
1Department of Pharmacy, Shenzhen Longgang Second People's Hospital, Shenzhen 518112, Guangdong, China.
类药物有效降低LDL胆固醇,但可能引起不良反应. 了解这些副作用,风险因素和遗传影响对于安全有效的心血管疾病管理至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心血管医学 心血管医学
- 遗传学 是一个遗传学.
背景情况:
- 升高的低密度脂蛋白 (LDL) 胆固醇是主要的心血管疾病风险因素.
- 类药物对于预防和治疗心血管疾病至关重要,可显著降低LDL胆固醇.
- 尽管耐受性很高,但他类药物的不良反应 (肝脏,脏,肌肉,糖尿病) 需要注意.
研究的目的:
- 审查他类药物诱导的不良反应,其机制和临床干预措施.
- 探索最大限度地提高他类药物的疗效和最大限度地减少副作用的策略.
- 为合理的他类药物应用和未来研究提供见解.
主要方法:
- 关于他类药物不良反应的临床表现的综合文献综述.
- 风险因素,药物相互作用和病因机制的分析.
- 评估当前的临床干预和未来的方向,包括基因检测.
主要成果:
- 副作用的详细概述:肌肉病,肝毒性,毒性,血糖影响,中枢神经系统影响,出血性中风.
- 确定影响他类药物的副作用的关键风险因素和药物/食物相互作用.
- 强调基因多样性在他类药物的不良影响中的作用.
结论:
- 优化他类药物治疗需要管理不良反应并最大限度地降低降脂效应.
- 基因检测可以个性化他类药物治疗,以减轻副作用.
- 均衡的风险-益处方法对于患者的益处和明智的临床实践至关重要.
更多相关视频
08:45LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
